Brainstorm Cell Therapeutics reported $316K in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Alterity Therapeutics Limited AUD 37.91M 15.92M Dec/2025
Biogen USD 7.58B 278.7M Sep/2026
Brainstorm Cell Therapeutics USD 316K 132K Jun/2026
Cipla INR 250.61B 9.14B Sep/2026
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 129.41M 7.88M Jun/2026
CSL USD 11.85B 1000K Dec/2025
Cytokinetics USD 1.19B 21.34M Sep/2026
Gilead Sciences USD 16.55B 4.02B Sep/2026
Grifols EUR 5.96B 316.31M Dec/2025
Halozyme Therapeutics USD 1.85B 913.71M Sep/2026
Mesoblast USD 197.49M 4.99M Jun/2026